…e its potential impact in patients with breast cancer receiving sacituzumab govitecan.Material and Methods We conducted a retrospective study in two …
sacituzumab govitecan
This drug is selected. Its supporting articles are shown below.
Articles mentioning sacituzumab govitecan
5 articles · page 1 of 1…), atezolizumab (Tecentriq), osimertinib (Tagrisso), ceritinib (Zykadia) and nintedanib (Vargatef). EMA labels for all products include…
…hat TROP2 targeting via hRS7, the antibody component of the ADC sacituzumab govitecan, enhances the anti-PD-1 response and improves T-cell accessibil…
…histology displayed a more pronounced immunological response to CAN-2409 treatment compared to patients with SQ histology. Improved immu…
…hat TROP2 targeting via hRS7, the antibody component of the ADC Sacituzumab govitecan (SG), enhances the anti-PD1 response and improves T cell access…